Taro

$59.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.83 (+1.42%) As of 1:44 PM EDT today

Why Robinhood?

You can buy or sell Taro and other stocks, options, and ETFs commission-free!

About TARO

Taro Pharmaceutical Industries Ltd., also called Taro, is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Read More The company was founded in 1950 and is headquartered in Haifa Bay, Israel. The listed name for TARO is Taro Pharmaceutical Industries Ltd.

Employees
1,464
Headquarters
Haifa Bay, Haifa
Founded
1950
Market Cap
2.27B
Price-Earnings Ratio
Dividend Yield
Average Volume
32.76K
High Today
$59.30
Low Today
$58.82
Open Price
$59.14
Volume
662.00
52 Week High
$99.69
52 Week Low
$53.95

Collections

TARO News

Benzinga19h

Taro to Announce Second Quarter Results on October 28, 2020

Earnings Call on Thursday, October 29th at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial re

TARO Earnings

$0.00
$0.65
$1.31
$1.96
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Estimated
per share
Actual
Available Oct 28, After Hours

You May Also Like